Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Feb;69(2):260–263. doi: 10.1038/bjc.1994.49

Products of vasopressin gene expression in small-cell carcinoma of the lung.

A S Friedmann 1, K A Malott 1, V A Memoli 1, S I Pai 1, X M Yu 1, W G North 1
PMCID: PMC1968694  PMID: 8297723

Abstract

Small-cell neuroendocrine carcinoma of the lung is known to express products related to the vasopressin gene, although these products have been reported to sometimes differ from those generated by neurones of the hypothalamo-neurohypophyseal system. To further investigate vasopressin gene expression in neuroendocrine carcinomas, we performed immunohistochemistry on 24 histologically classified small-cell carcinomas using antibodies directed against different regions of the vasopressin precursor. All of the tumours examined contained at least two parts of the vasopressin precursor, suggesting that vasopressin might have a biological role in these tumours and indicating a role for these products in tumour diagnosis and treatment. Sixty-seven per cent of the tumours contained immunoreactivity for all major regions of the precursor: vasopressin, vasopressin-associated human neurophysin, the bridging region between the hormone and the neurophysin, and vasopressin-associated human glycopeptide. However, 33% of the tumours examined appeared to express only part of the vasopressin precursor, as evidenced by the absence of immunoreactivity for the neurophysin and/or the glycopeptide. These results support the proposition that both normal and abnormal vasopressin gene expression occurs in small-cell carcinoma of the lung.

Full text

PDF
260

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almenoff P. L., Rieg T. S., Lauterio T. J., Aravich P. F. Lung-immunoreactive vasopressin is increased by exercise and decreased by obesity in the rat. Ann N Y Acad Sci. 1993 Jul 22;689:458–460. doi: 10.1111/j.1749-6632.1993.tb55568.x. [DOI] [PubMed] [Google Scholar]
  2. Gross A. J., Steinberg S. M., Reilly J. G., Bliss D. P., Jr, Brennan J., Le P. T., Simmons A., Phelps R., Mulshine J. L., Ihde D. C. Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res. 1993 Jan 1;53(1):67–74. [PubMed] [Google Scholar]
  3. Moses A. M., Scheinman S. J. Ectopic secretion of neurohypophyseal peptides in patients with malignancy. Endocrinol Metab Clin North Am. 1991 Sep;20(3):489–506. [PubMed] [Google Scholar]
  4. North W. G., Hirsh V., Lisbona R., Schultz J., Cooper B. Imaging of small cell carcinoma using 131I-labelled antibodies to vasopressin associated human neurophysin (VP-HNP) Nucl Med Commun. 1989 Sep;10(9):643–652. doi: 10.1097/00006231-198909000-00003. [DOI] [PubMed] [Google Scholar]
  5. North W. G., LaRochelle F. T., Jr, Melton J., Mills R. C. Isolation and partial characterization of two human neurophysins: their use in the development of specific radioimmunoassays. J Clin Endocrinol Metab. 1980 Oct;51(4):884–891. doi: 10.1210/jcem-51-4-884. [DOI] [PubMed] [Google Scholar]
  6. North W. G., Maurer L. H., Valtin H., O'Donnell J. F. Human neurophysins as potential tumor markers for small cell carcinoma of the lung: application of specific radioimmunoassays. J Clin Endocrinol Metab. 1980 Oct;51(4):892–896. doi: 10.1210/jcem-51-4-892. [DOI] [PubMed] [Google Scholar]
  7. North W. G. Neuropeptide production by small cell carcinoma: vasopressin and oxytocin as plasma markers of disease. J Clin Endocrinol Metab. 1991 Dec;73(6):1316–1320. doi: 10.1210/jcem-73-6-1316. [DOI] [PubMed] [Google Scholar]
  8. North W. G., Ware J., Maurer L. H., Chahinian A. P., Perry M. Neurophysins as tumor markers for small cell carcinoma of the lung. A cancer and Leukemia Group B evaluation. Cancer. 1988 Oct 1;62(7):1343–1347. doi: 10.1002/1097-0142(19881001)62:7<1343::aid-cncr2820620717>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  9. North W. G., Yu X. M. Vasopressin mRNA and neurophysin-related cell-surface antigen (NRSA) in small-cell carcinoma. Peptides. 1993 Mar-Apr;14(2):303–307. doi: 10.1016/0196-9781(93)90045-i. [DOI] [PubMed] [Google Scholar]
  10. Rosenbaum L. C., Neuwelt E. A., Van Tol H. H., Loh Y. P., Verbalis J. G., Hellström I., Hellström K. E., Nilaver G. Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9928–9932. doi: 10.1073/pnas.87.24.9928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SCHWARTZ W. B., BENNETT W., CURELOP S., BARTTER F. C. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957 Oct;23(4):529–542. doi: 10.1016/0002-9343(57)90224-3. [DOI] [PubMed] [Google Scholar]
  12. Sato Y., Mukai K., Watanabe S., Goto M., Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol. 1986 Dec;125(3):431–435. [PMC free article] [PubMed] [Google Scholar]
  13. Streefkerk J. G. Inhibition of erythrocyte pseudoperoxidase activity by treatment with hydrogen peroxide following methanol. J Histochem Cytochem. 1972 Oct;20(10):829–831. doi: 10.1177/20.10.829. [DOI] [PubMed] [Google Scholar]
  14. Verbeeck M. A., Elands J. P., de Leij L. F., Buys C. H., Carney D. N., Bepler G., Roebroeck A. J., Van de Ven W. J., Burbach J. P. Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines. Pathobiology. 1992;60(3):136–142. doi: 10.1159/000163712. [DOI] [PubMed] [Google Scholar]
  15. Yamaji T., Ishibashi M., Hori T. Propressophysin in human blood: a possible marker of ectopic vasopressin production. J Clin Endocrinol Metab. 1984 Sep;59(3):505–512. doi: 10.1210/jcem-59-3-505. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES